REIN THERAPEUTICS INC (RNTX) Stock Income Statement
NASDAQ:RNTX - US00887A2042 - Common Stock
1.35 USD
-0.04 (-2.88%)
1.4 USD
+0.05 (+3.7%)
| TTM (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Operating Expenses | 24.35M | 28.11M | 15.35M | 27.65M | 26.61M | |||
| Research and Development | 14.39M | 14.25M | 3.99M | 17.97M | 17.01M | |||
| Selling, General, and Administrative Expenses | 9.96M | 13.86M | 11.36M | 9.68M | 9.60M | |||
| Operating Income | -24.35M | -28.11M | -15.35M | -27.65M | -26.61M | |||
| Interest Income/Expense | N/A | 400.00K | 400.00K | 300.00K | N/A | |||
| Other Income/Expense | 653.00K | 285.00K | 144.00K | 20.00K | 40.00K | |||
| Non Recurring Items | N/A | -37.00M | -928.00K | N/A | 300.00K | |||
| Income Before Taxes | -60.70M | -64.43M | -15.73M | -27.33M | -26.16M | |||
| Income Tax | N/A | -1.54M | N/A | N/A | N/A | |||
| Net Income | -59.15M | -62.88M | -15.73M | -27.33M | -26.16M | |||
| EBITDA | N/A | -28.05M | -15.23M | -27.48M | -26.49M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -2.69 | -3.51 | -3.42 | -6.02 | -5.89 | |||
| Non GAAP EPS | -3.00 | -3.78 | N/A | -6.02 | -5.80 | |||
| Statistics | ||||||||
All data in USD